Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $66 | $26 | $17 | $30 |
| - Cash | $22 | $12 | $41 | $42 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $44 | $14 | -$24 | -$12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$35 | -$32 | -$14 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$35 | -$31 | -$14 | -$22 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.17 | -24.92 | -19.96 | -38.854 |
| % Growth | 51.2% | -24.8% | 48.6% | – |
| Operating Cash Flow | -$31 | -$29 | -$8 | -$17 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$31 | -$29 | -$8 | -$17 |